What is an organoid?
An organoid is a three-dimensional tissue grown from stem cells that reproduces some of the cell types, architecture, and function of a real organ. It is a model of an organ, not a miniature one, and that distinction is where most of the confusion starts.
Organoids matter to two audiences at once. Pharmacology wants human tissue that responds to a drug more like a patient than a flat cell line or a mouse does. Biocomputing wants neural tissue dense and connected enough to compute. The same cleanroom, bioreactors, and quality control serve both. What follows is how that tissue is actually made and trusted.
How is an organoid grown?
Production starts from human induced pluripotent stem cells, expanded clonally under defined media. Differentiation is triggered with chemical cues; the cells form embryoid bodies, which are embedded in an extracellular matrix gel and moved into spinning bioreactors that keep nutrients and oxygen circulating so the growing tissue does not suffocate at its core. Over weeks to months the cells self-organize into organ-like structure. The art is reproducibility: making the next thousand organoids resemble the last thousand.
How do you know a batch is good?
Reproducibility is enforced, not assumed. Automated high-content confocal imaging checks each batch on a schedule: a neural organoid must show cortical-like layering, mature synaptic networks, and no central necrosis. Bioreactors log pH, dissolved oxygen, and glucose consumption, and feedback loops adjust gas and perfusion to hold conditions steady. Anything off-spec is flagged and decommissioned. For toxicology or biocomputing, the result is the same requirement: the assay runs only on tissue that passed QC.
The organ models, and what they are good for
Three organ models do most of the work, each read out by a different sensor because each organ signals differently.
| Model | Primary use | Readout interface |
|---|---|---|
| Cerebral (brain) | Neural computation, plasticity, neurotoxicity | Planar and 3D microelectrode arrays |
| Hepatic (liver) | Drug metabolism and toxicity screening | Microfluidic metabolic sensors |
| Renal (kidney) | Nephrotoxicity, barrier integrity | Transepithelial electrical resistance (TEER) |
The cerebral model is the bridge to the rest of this network: the same tissue that screens a neurotoxin can, on the same kind of array, act as a computing substrate. That overlap is the subject of the biocomputing primer. The commercial screening side is covered under drug discovery.
Frequently asked questions
What is an organoid in simple terms?
A small three-dimensional tissue grown from stem cells that reproduces some of the structure and function of a real organ. It is a model of an organ, not a shrunken organ.
How long does it take to grow one?
Weeks to months. Neural organoids typically need 30 to 120 days to develop layered structure and active synaptic networks.
Is a brain organoid a tiny brain?
No. It reproduces some developmental and electrophysiological features of brain tissue but lacks a body, blood supply, full architecture, and sensory input. It is a model, not a miniature brain.
Why are organoids useful for drug screening?
Because human organoids respond to compounds more like human tissue than flat cell lines or animal models do, improving how predictive a preclinical screen is.
References
- Lancaster MA, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501(7467):373-379. doi:10.1038/nature12517. Accessed 2026-06-12.
- Clevers H. Modeling development and disease with organoids. Cell. 2016;165(7):1586-1597. doi:10.1016/j.cell.2016.05.082. Accessed 2026-06-12.
- Smirnova L, et al. Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish. Frontiers in Science. 2023;1:1017235. doi:10.3389/fsci.2023.1017235. Accessed 2026-06-12.